World Bulletin / News Desk
EU antitrust regulators charged Danish drugmaker Lundbeck, German peer Merck KGaA and seven other firms with blocking the entry of cheaper generic medicines into the market, in a move that could lead to big fines for the companies.
The charges against Lundbeck and the eight other firms are the first by the EU watchdog against "pay-for-delay" deals -- where brand-name companies pay generic competitors to abstain from putting their rival drugs on the market -- since a high-profile inquiry into the sector in 2009.
The European Commission said on Wednesday the tactic breached EU antitrust rules. It also warned French drugmaker Servier and several generic rivals of further action in the coming days for a similar offence, related to another medicine.
Regulators had said then that such delays cost European consumers billions of euros. Reuters reported on Tuesday that the EU watchdog would act against Lundbeck and Servier.
Companies can be fined up to 10 percent of their turnover if found guilty of breaching EU rules. Lundbeck posted 16 billion Danish crowns ($2.60 billion) in revenues last year.
The Commission said Lundbeck's action together with four generic competitors related to the antidepressant citalopram.
"The companies entered into agreements that foresaw substantial value transfers from Lundbeck to its four generic competitors, who subsequently abstained from entering the market with generic citalopram," the Commission said in a statement.
"The value transfers included direct payments from Lundbeck to the generic competitors and also occurred in other forms, such as the purchase of generic citalopram stock for destruction or guaranteed profits in a distribution agreement," it said.
The Commission has been stepping up scrutiny of settlements between drug companies in recent years over concerns some may prevent consumers from obtaining lower-priced medicines.
Lundbeck said it did not believe it had broken EU rules.
"Lundbeck vigorously opposes any allegation of wrongdoing and does not believe its practice has violated European competition law," the company said in a statement in Copenhagen.
The EU watchdog also sent the "statement of objections" or charge sheet to Generics UK, Arrow, Resolution Chemicals, Xellia Pharmaceuticals, Alpharma, A.L. Industrier and Ranbaxy .
On Servier, the Commission said it planned to act against the company and several generic competitors soon.
"Servier and several generic competitors entered into agreements which may have hindered the entry of generic perindopril into markets in the EU," the regulators said.
"In the context of this investigation, the Commission is also looking at the unilateral behaviour of Servier."
Given all the uncertainty, investors were pricing in a chance of a rate cut with some analysts expecting the Bank of England to consider quantitative easing to cushion the economy
The Egyptian stock index was down 5.8 percent in early afternoon.
The pound sterling sees its lowest level against the the US dollar in over 30 years
A subsequent survey that included people of all ages found that somewhat older Americans also are skeptical of capitalism.
California is now the sixth largest economy in the world, surpassing France thanks to a robust state economy and the strength of the US dollar.
Overnight lending rate gets cut by 50 points to 9 percent, while overnight borrowing rate remains unchanged at 7.25 percent
Says 2016 business report 'clear indicator' it is improving its economic record despite fall from 46th to 49th
Turkish Cypriot leader says negotiations on federal system close to completion
Britain votes on June 23 on whether to stay in the 28-member bloc, a choice with far-reaching consequences for politics, the economy, defence and diplomacy on the continent.
1 in 18 families has a member who left Greece after 2010, and 12 pct of new refugees are older than 40
Surplus during Jan.-May period stood at $3.1 billion, says finance minister
Remote, impoverished town expects well-to-do Chinese buyer to spur its fragile economy
Austrian company is to have 75 percent of total stakes of Turkish company after agreement concluded
Apple, Microsoft, Alphabet, Cisco and Oracle hold about $504B, approximately one-third of all corporate cash in the United States
The Fund's head says 'corruption has a pernicious effect on the economy'